Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: Results of a prospective long-term follow-up
Elisabeth Ejerblad(Uppsala University), Gunnar Birgegård(Uppsala University Hospital), Berit Markevärn, Eva Löfvenberg(Karolinska University Hospital), Magnus Björkholm(Karolinska Institutet), Jan Samuelsson(Karolinska University Hospital), Björn Andréasson(NU Hospital Group), Hans Michael Kvasnicka(Helios Universitätsklinikum Wuppertal), Mats Merup(Karolinska University Hospital), Jan Palmblad(Karolinska Institutet), Jürgen Thiele, Lars Nilssson(Lund University)
Cited by 30
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
|Journal of Clinical Oncology|2012|461
High mobility group 1 B‐box mediates activation of human endothelium
|Journal of Internal Medicine|2003|329